Annual report pursuant to Section 13 and 15(d)

Revenue Recognition and Contracts with Customers

Revenue Recognition and Contracts with Customers
12 Months Ended
Dec. 31, 2020
Revenue Recognition and Contracts with Customers  
Revenue Recognition and Contracts with Customers

Note 2 – Revenue Recognition and Contracts with Customers

Disaggregated Revenue

The Company’s total revenue was comprised of four major product lines: Smart Glasses, OEM Product Sales, Waveguide and Display Engine Sales, and Engineering Services. The following table summarizes the revenue recognized by major product line:

For the Years Ended December 31, 












Smart Glasses Sales







OEM Product Sales






Waveguide and Display Engine Sales






Engineering Services







Total Revenue







Significant Judgments

Under Topic 606, there are judgments used that could potentially impact both the timing of our satisfaction of performance obligations and our determination of transaction prices used in determining revenue recognized by major product line. Judgments made include considerations in determining our transaction prices for our standard product sales that include an end-user 30-day right to return if not satisfied with product and include general payment terms that are between Net 30 and 60 days. For our Engineering Services, performance obligations are recognized over time using the input method and the estimated costs to complete each project are considered significant judgments.

Performance Obligations

Revenues from our performance obligations are typically satisfied at a point in time for Smart Glasses, Waveguides and Display Engines, and our OEM Products, which are recognized when the customer obtains control and ownership, which is generally upon shipment. The Company also records revenue for performance obligations relating to our Engineering Services over time by using the input method measuring progress toward satisfying the performance obligations. Satisfaction of our performance obligations related to our Engineering Services is measured by the Company’s cost incurred as a percentage of total expected costs to project completion as the inputs of actual costs incurred by the Company are directly correlated with progress of completing the contract. As such, the Company believes that our methodologies for recognizing revenue over time for our Engineering Services correlate directly with the transfer of control of the underlying assets to our customers.

Our standard product sales include a twelve (12) month assurance-type product warranty, except in certain European countries where it can be twenty-four (24) months for some consumer-focused products. In the case of our OEM products and waveguide sales, some include a standard product warranty of up to eighteen (18) months. In 2018, we began offering extended warranties to customers, which extend the standard product warranty on product sales for an additional twelve (12) month period. All revenue related to extended product warranty sales is deferred and recognized over the extended warranty period. For the year ended December 31, 2020, a total of $123,000 was recognized as revenue for the remaining performance obligations that existed as of December 31, 2019 for our extended warranty obligations. As of December 31, 2020, there was no outstanding performance obligtions remaining for extended warranties. Our engineering services contracts vary from contract to contract but typically include payment terms of Net 30 days from date of billing, subject to an agreed upon customer acceptance period.

The following table presents a summary of the Company’s net sales by revenue recognition method as a percentage of total net sales for the year ended December 31, 2020:


% of Total Net Sales






Over Time – Input Method








Remaining Performance Obligations

As of December 31, 2020, the Company had approximately $169,000 of remaining performance obligations under a current waveguide engineering services development project with a rapidly developing micro-display organization and a M4000 camera integration project with an innovative health technologies organization, which represents the remainder of the total transaction price of these development agreements of $387,000, less revenue recognized under percentage of completion for the year ended December 31, 2020. The Company currently expects to recognize the remaining majority of the revenues relating to these existing performance obligations of $169,000 in the first quarter of 2021.